SATB2 and neoplasm: Downregulation of Wnt/β-catenin signaling and subsequent modulation of chromatin organizers SATB1 (oncogenic) and SATB2 (tumor suppressor), leading to reversal of epithelial-mesenchymal transition (EMT).